The effect of electrical stimulation of the brain, in patients with obsession disorder

Investigation the effect of transcranial direct current stimulation (tDCS) of the brain, as an adjunct to Fluexthine for patient with Obssesive-Compulsive Disorder: A clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017030632904N1

Enrollment

Registered

2017-07-14

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder. Obsessive-Compulsive Disorder

Interventions

Intervention 1: Control group: Patients will attach through electrodes to the tDCS device, with 2 mA, for 20 minutes (8 weeks, 3 sessions per week)

but stimulation will not be applied. Intervention 2: Intervention Group: Transcranial direct electrical stimulation of the brain with 2 mA, for 20 minutes (8 weeks, 3 sessions per week) using tDCS de

Treatment - Devices

Control group: Patients will attach through electrodes to the tDCS device, with 2 mA, for 20 minutes (8 weeks, 3 sessions per week)

but stimulation will not be applied.

Intervention Group: Transcranial direct electrical stimulation of the brain with 2 mA, for 20 minutes (8 weeks, 3 sessions per week) using tDCS device

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: The Yale Brown score 20 or more; Age 20 to 60 years; Medication with Fluoxetine; Having at least primary education Exclusion criteria: Lack of cooperation during study despite adequate explanation; Having heart disease; Having neurological disease; Medication except Fluoxetine; Use of benzodiazepines and other antihistamines; ECT in the past two months; Existence of electronic devices and metal in the body; Exacerbation of disease and suicidal thoughts; Pregnancy; Having other psychiatric disorders; Having physical disease; Mental retardation; History of drug and alcohol abuse

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical feature of OCD. Timepoint: pre-intervention, at 4, 8 and 12 weeks throughout the intervention. Method of measurement: Yale-Brown Obsessive Compulsive Scale (YBOCS).	—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVictoria Safari

Arak University of Medical Sciences

ms.prn74@yahoo.com+98 86 3313 5075

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 25, 2026